Dual Immune Check Point Blockade in &lt;i&gt;MGMT&lt;/i&gt;-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial
National Cancer Institute (NCI)
Andrew B Lassman; Mei-Yin C Polley; Fabio M Iwamoto; Andrew E Sloan; Tony J C Wang; Kenneth D Aldape; Jeffrey S Wefel; Vinai Gondi; Alonso N Gutierrez; Mohammed H Manasawala; Mark R Gilbert; Erik P Sulman; Jedd D Wolchok; Richard M Green; Elizabeth C Neil; Rimas V Lukas; Samuel A Goldlust; Matija Snuderl; Kristyn Galbraith; James J Dignam; Minhee Won; Minesh P Mehta
NRG Oncology Statistics and Data Management Center, Philadelphia, PA. ; NRG Oncology Statistics and Data Management Center, Philadelphia, PA.